Literature DB >> 3762159

Measurement of depression in alcoholics.

M L Willenbring.   

Abstract

Estimates of the prevalence of depression among alcoholics vary widely, partly because of different methods used to define depression. To assess the specificity, sensitivity, change over time and agreement of several common methods, 52 men alcoholics were studied. Using DSM-III diagnosis by clinical interview as the standard, the Hamilton Depression Scale (Ham-D) showed high sensitivity, high specificity and good agreement with DSM-III. The Beck Depression Inventory and the Depression Scale of the Minnesota Multiphasic Personality Inventory were not sensitive enough for screening purposes. Both self-report measures correlated more highly with the Ham-D and clinical interview than with each other. The dexamethasone suppression test had both low sensitivity and low specificity. All measures showed significant improvement over three weeks. More attention should be paid to using DSM-III criteria or the Ham-D instead of self-report scales in screening for depression among alcoholics.

Entities:  

Mesh:

Year:  1986        PMID: 3762159     DOI: 10.15288/jsa.1986.47.367

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  11 in total

1.  Comorbid depression and substance use disorder: longitudinal associations between symptoms in a controlled trial.

Authors:  Matthew J Worley; Ryan S Trim; Scott C Roesch; Jennifer Mrnak-Meyer; Susan R Tate; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2012-03-08

Review 2.  Risks of combined alcohol/medication use in older adults.

Authors:  Alison A Moore; Elizabeth J Whiteman; Katherine T Ward
Journal:  Am J Geriatr Pharmacother       Date:  2007-03

3.  Service utilization during and after outpatient treatment for comorbid substance use disorder and depression.

Authors:  Matthew J Worley; Ryan S Trim; Susan R Tate; Jessica E Hall; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2010-07-03

4.  Depressive symptomatology and early attrition from intensive outpatient substance use treatment.

Authors:  Geoffrey M Curran; JoAnn E Kirchner; Mark Worley; Craig Rookey; Brenda M Booth
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

5.  Chronic physical health problems moderate changes in depression and substance use among dual diagnosed individuals during and after treatment.

Authors:  Ruifeng Cui; Susan R Tate; Kevin Cummins; Jessica R Skidmore; Sandra A Brown
Journal:  Subst Use Misuse       Date:  2014-10-07       Impact factor: 2.164

6.  Clinical outcomes of an integrated treatment for depression and substance use disorders.

Authors:  Katherine P Lydecker; Susan R Tate; Kevin M Cummins; John McQuaid; Eric Granholm; Sandra A Brown
Journal:  Psychol Addict Behav       Date:  2010-09

7.  Mediated and moderated effects of neurocognitive impairment on outcomes of treatment for substance dependence and major depression.

Authors:  Matthew J Worley; Susan R Tate; Eric Granholm; Sandra A Brown
Journal:  J Consult Clin Psychol       Date:  2014-03-03

8.  Does initial treatment focus influence outcomes for depressed substance abusers?

Authors:  Michelle L Drapkin; Susan R Tate; John R McQuaid; Sandra A Brown
Journal:  J Subst Abuse Treat       Date:  2008-03-04

9.  On the implication of structural zeros as independent variables in regression analysis: applications to alcohol research.

Authors:  Hua He; Wenjuan Wang; Paul Crits-Christoph; Robert Gallop; Wan Tang; Ding-Geng Din Chen; Xin M Tu
Journal:  J Data Sci       Date:  2014-07

10.  Impact of Physical Health on Treatment for Co-occurring Depression and Substance Dependence.

Authors:  Jessica C Tripp; Jessica R Skidmore; Ruifeng Cui; Susan R Tate
Journal:  J Dual Diagn       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.